
Bahar Alawi Craigo
Examiner (ID: 2673, Phone: (571)270-1326 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1699, 1759, 1673, 1623, 4131 |
| Total Applications | 905 |
| Issued Applications | 360 |
| Pending Applications | 129 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17088547
[patent_doc_number] => 11116715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Composition for dermal injection
[patent_app_type] => utility
[patent_app_number] => 16/489363
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5700
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489363 | Composition for dermal injection | Feb 26, 2018 | Issued |
Array
(
[id] => 15432351
[patent_doc_number] => 20200030358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => USE OF VITAMIN COMPOSITION IN PREPARING DRUG FOR PREVENTING, TREATING, OR DELAYING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/491560
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491560
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491560 | Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease | Feb 23, 2018 | Issued |
Array
(
[id] => 17307333
[patent_doc_number] => 11208425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Process for preparing polyol glycosides
[patent_app_type] => utility
[patent_app_number] => 15/900544
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9493
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900544 | Process for preparing polyol glycosides | Feb 19, 2018 | Issued |
Array
(
[id] => 13368899
[patent_doc_number] => 20180235990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => FLAVONOID COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 15/884118
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15884118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/884118 | Flavonoid compositions and related methods | Jan 29, 2018 | Issued |
Array
(
[id] => 16619968
[patent_doc_number] => 20210038621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => PHARMACEUTICAL AGENT FOR IMPROVING AUTISM SPECTRUM DISORDER AND MENTAL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/964910
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964910 | Pharmaceutical agent for improving autism spectrum disorder and mental disease | Jan 25, 2018 | Issued |
Array
(
[id] => 13479021
[patent_doc_number] => 20180291053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => AZIRIDINE SPINOSYN DERIVATIVES AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 15/861368
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861368 | Aziridine spinosyn derivatives and methods of making | Jan 2, 2018 | Issued |
Array
(
[id] => 15117103
[patent_doc_number] => 20190345184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => METHOD OF DEGRADING POLYSACCHARIDE USING OZONE
[patent_app_type] => utility
[patent_app_number] => 16/474350
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474350 | Method of degrading polysaccharide using ozone | Dec 26, 2017 | Issued |
Array
(
[id] => 16506161
[patent_doc_number] => 20200385417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => COMPOSITION OF MANNURONIC DIACID
[patent_app_type] => utility
[patent_app_number] => 16/474928
[patent_app_country] => US
[patent_app_date] => 2017-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474928 | Composition of mannuronic diacid | Dec 26, 2017 | Issued |
Array
(
[id] => 15117105
[patent_doc_number] => 20190345185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => CONTINUOUS PROCESS FOR HYDROGENATION OF MALTOSE TO MALTITOL
[patent_app_type] => utility
[patent_app_number] => 16/472014
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472014 | CONTINUOUS PROCESS FOR HYDROGENATION OF MALTOSE TO MALTITOL | Dec 18, 2017 | Abandoned |
Array
(
[id] => 14960611
[patent_doc_number] => 20190307783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => USE OF ANTIVIRALS TO INHIBIT PROTOZOAN VIRUSES
[patent_app_type] => utility
[patent_app_number] => 16/467875
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467875 | USE OF ANTIVIRALS TO INHIBIT PROTOZOAN VIRUSES | Dec 6, 2017 | Abandoned |
Array
(
[id] => 15117269
[patent_doc_number] => 20190345267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => IN SITU FUNCTIONALIZATION OF POLYSACCHARIDES AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/461508
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461508 | IN SITU FUNCTIONALIZATION OF POLYSACCHARIDES AND COMPOSITIONS THEREOF | Nov 19, 2017 | Abandoned |
Array
(
[id] => 12233142
[patent_doc_number] => 20180066005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'TRANS-RESVERATROL POLYSACCHARIDE, METHOD OF PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/808181
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10561
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15808181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/808181 | TRANS-RESVERATROL POLYSACCHARIDE, METHOD OF PRODUCING THE SAME, AND COMPOSITION COMPRISING THE SAME | Nov 8, 2017 | Abandoned |
Array
(
[id] => 17602869
[patent_doc_number] => 11331338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Hydrogen sulfide releasing polymer compounds
[patent_app_type] => utility
[patent_app_number] => 16/348012
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 11084
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348012
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348012 | Hydrogen sulfide releasing polymer compounds | Nov 6, 2017 | Issued |
Array
(
[id] => 17726560
[patent_doc_number] => 11382925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Agent for treating retinal disease
[patent_app_type] => utility
[patent_app_number] => 16/761664
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2582
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761664
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761664 | Agent for treating retinal disease | Nov 6, 2017 | Issued |
Array
(
[id] => 12185505
[patent_doc_number] => 20180044440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'BETA-1,3-GLUCAN DERIVATIVE AND METHOD FOR PRODUCING BETA-1,3-GLUCAN DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/790272
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27936
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/790272 | BETA-1,3-GLUCAN DERIVATIVE AND METHOD FOR PRODUCING BETA-1,3-GLUCAN DERIVATIVE | Oct 22, 2017 | Abandoned |
Array
(
[id] => 14682227
[patent_doc_number] => 20190240228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => PURINE DERIVATIVE FOR USE IN THE TREATMENT OR PREVENTION OF DISEASES CAUSED BY A NONSENSE MUTATION
[patent_app_type] => utility
[patent_app_number] => 16/342640
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342640 | Purine derivative for use in the treatment or prevention of diseases caused by a nonsense mutation | Oct 19, 2017 | Issued |
Array
(
[id] => 12177423
[patent_doc_number] => 20180036358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/785034
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12870
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/785034 | COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS | Oct 15, 2017 | Abandoned |
Array
(
[id] => 17029706
[patent_doc_number] => 11091511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Panaxdiol-type ginsenoside derivative, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/333803
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15930
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333803 | Panaxdiol-type ginsenoside derivative, preparation method therefor and use thereof | Sep 14, 2017 | Issued |
Array
(
[id] => 17997845
[patent_doc_number] => 11498939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Glucose polymers for peritoneal dialysis
[patent_app_type] => utility
[patent_app_number] => 16/332169
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7319
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332169
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332169 | Glucose polymers for peritoneal dialysis | Sep 13, 2017 | Issued |
Array
(
[id] => 15239781
[patent_doc_number] => 20190374676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => A CROSS-LINKED STRUCTURE FOR TISSUE REGENERATION AND ENGINEERING AND THE METHOD FOR SYNTHESISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/335932
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335932 | A CROSS-LINKED STRUCTURE FOR TISSUE REGENERATION AND ENGINEERING AND THE METHOD FOR SYNTHESISING SAME | Aug 9, 2017 | Abandoned |